Alamar Biosciences (ALMR) vs Precipio (PRPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alamar Biosciences is the larger company by market cap ($1.78 billion vs $41.7 million), about 42.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | PRPO |
|---|---|---|
| Share price | $25.61 | $23.27 |
| Market cap | $1.78B | $41.66M |
| 1-day change | -1.16% | +0.34% |
| YTD return | — | +0.91% |
| 1-year return | — | +26.38% |
| 5-year return | — | -54.71% |
| Forward P/E | — | 59.67 |
| EPS (TTM) | $-1.20 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $39.61 | $33.63 |
| 52-week low | $18.85 | $16.40 |
| Distance from 52-week high | -35.34% | -30.81% |
| Analyst consensus | buy | — |
| Avg. price target upside | +38.23% | — |
| Average volume | 411.15K | 127.60K |
| Shares outstanding | 69.39M | 1.79M |
| Employees | 286 | 61 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alamar Biosciences is about 42.7 times larger than Precipio by market value ($1.78B vs $41.66M).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Precipio
PRPO stock →Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 61 employees
ALMR vs PRPO FAQ
Which is bigger, Alamar Biosciences or Precipio?
Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.78B compared with $41.66M for Precipio (PRPO).
Are Alamar Biosciences and Precipio in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.